Victoria Forster, PhD

Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.

Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.

Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.

Outcomes of lenvatinib-receiving patients who progressed to Child-Pugh B liver function within the first 8 weeks of treatment were compared with those of patients who maintained Child-Pugh A classification during the same time period.

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.

IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.

A combination of pembrolizumab and an antibody-drug conjugate demonstrated a 73% overall response rate in a phase 1/2 clinical trial.